Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)

Pharmaceutical Preparations

https://www.amneal.com

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/07/2018

Market Cap

2,487,178,069

Shares Outstanding

306,540,000

Weighted SO

306,544,199

Total Employees

N/A

Upcoming Earnings

08/09/2024

Beta

1.2310

Last Div

0.0000

Range

3.36-8.15

Chg

0.1250

Avg Vol

1472085

Mkt Cap

2487178069

Exch

NYSE

Country

US

Phone

908 947 3120

DCF Diff

-14.0833

DCF

22.1183

Div Yield

0.0000

P/S

0.9573

EV Multiple

18.4064

P/FV

-43.2220

Div Yield %

0.0000

P/E

-15.1612

PEG

-1.4630

Payout

0.0000

Current Ratio

1.3330

Quick Ratio

0.8165

Cash Ratio

0.0393

DSO

108.1616

DIO

124.4960

Op Cycle

232.6575

DPO

0.0000

CCC

232.6575

Gross Margin

0.3504

Op Margin

0.0672

Pretax Margin

-0.0445

Net Margin

-0.0631

Eff Tax Rate

-0.1521

ROA

-0.0467

ROE

-12.4043

ROCE

0.0729

NI/EBT

1.4169

EBT/EBIT

-0.6623

EBIT/Rev

0.0672

Debt Ratio

0.7254

D/E

-44.3076

LT Debt/Cap

1.0259

Total Debt/Cap

1.0231

Int Coverage

-8.3265

CF/Debt

0.0791

Equity Multi

-61.0793

Rec Turnover

3.3746

Pay Turnover

0.0000

Inv Turnover

2.9318

FA Turnover

4.9117

Asset Turnover

0.7402

OCF/Share

0.6517

FCF/Share

0.4019

Cash/Share

0.1416

OCF/Sales

0.0775

FCF/OCF

0.6167

CF Coverage

0.0791

ST Coverage

0.7389

CapEx Coverage

2.6091

Div&CapEx Cov

2.6091

P/BV

-43.2220

P/B

-43.2220

P/S

0.9573

P/E

-15.1612

P/FCF

20.0187

P/OCF

12.3291

P/CF

12.3291

PEG

-1.4630

P/S

0.9573

EV Multiple

18.4064

P/FV

-43.2220

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation